[HTML][HTML] Approach to pulmonary arteriovenous malformations: a comprehensive update

S Majumdar, JP McWilliams - Journal of Clinical Medicine, 2020 - mdpi.com
Pulmonary arteriovenous malformations (PAVMs) are abnormal direct vascular
communications between pulmonary arteries and veins which create high-flow right-to-left …

Brain abscess in pediatric age: a review

C Mameli, T Genoni, C Madia, C Doneda… - Child's Nervous …, 2019 - Springer
Objective The purpose of the paper is to examine the current state of the art about
epidemiology, diagnosis, and treatment of this infection. Methods A review of the literature …

Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and …

KJ Monahan, N Bradshaw, S Dolwani, B Desouza… - Gut, 2020 - gut.bmj.com
Heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost
30% of the population in the UK have a family history of CRC. The quantification of an …

[HTML][HTML] European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia (HHT)

CL Shovlin, E Buscarini, AD Kjeldsen, HJ Mager… - Orphanet Journal of …, 2018 - Springer
Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia that
leads to nosebleeds, anaemia due to blood loss, and arteriovenous malformations (AVMs) …

Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia

CL Shovlin, I Simeoni, K Downes… - Blood, The Journal …, 2020 - ashpublications.org
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia.
Care delivery for HHT patients is impeded by the need for laborious, repeated phenotyping …

[HTML][HTML] The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care

CL Shovlin, E Buscarini, C Sabbà, HJ Mager… - European Journal of …, 2022 - Elsevier
Hereditary haemorrhagic telangiectasia (HHT) is a complex, multisystemic vascular
dysplasia affecting approximately 85,000 European Citizens. In 2016, eight founding centres …

Embolisation for pulmonary arteriovenous malformation

CCT Hsu, GNC Kwan, SA Thompson… - Cochrane Database …, 2012 - cochranelibrary.com
Background Pulmonary arteriovenous malformations are abnormal direct connections
between the pulmonary artery and pulmonary vein which result in a right‐to‐left shunt. They …

[HTML][HTML] Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia

E Buscarini, LM Botella, U Geisthoff… - Orphanet Journal of …, 2019 - Springer
Background Hereditary hemorrhagic telangiectasia (HHT) is a multisystemic inherited
vascular dysplasia that leads to nosebleeds and visceral arteriovenous malformations …

Hereditary hemorrhagic telangiectasia: the convergence of genotype, phenotype, and imaging in modern diagnosis and management of a multisystem disease

SW Hetts, JT Shieh, MA Ohliger, MB Conrad - Radiology, 2021 - pubs.rsna.org
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease that
manifests as vascular malformations in the brain, lung, liver, gastrointestinal tract, nasal …

[HTML][HTML] Pulmonary vascular complications in hereditary hemorrhagic telangiectasia and the underlying pathophysiology

S Bofarid, AE Hosman, JJ Mager, RJ Snijder… - International journal of …, 2021 - mdpi.com
In this review, we discuss the role of transforming growth factor-beta (TGF-β) in the
development of pulmonary vascular disease (PVD), both pulmonary arteriovenous …